Sign In
Buy XPHYF
$0.284
+0 (+0%)
At Close: Apr 17, 2023
XPhyto Announces Advertising Agreement with Agora Internet Relations Corp.
08:25pm, Friday, 02'nd Jul 2021
VANCOUVER, BC / ACCESSWIRE / July 2, 2021 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company") announces that pursuant to its advertising agreement with AGORA Inter
XPhyto supplies 10 test centers in Berlin with its 25-minute COVID-19 PCR tests
07:44am, Wednesday, 30'th Jun 2021
XPhyto Therapeutics Corp (CSE:XPHY) (OTCMKTS:XPHYF) (FRA:4XT) revealed that it has signed a master supply agreement with Beovita GmbH & Company KG and Tackleberries GmbH, two German diagnostics, testi
XPhyto Supplies 10 Test Centers in Berlin with 25-minute COVID-19 PCR Test
03:05am, Wednesday, 30'th Jun 2021
XPhyto signs master supply agreement with operator of 10 COVID-19 test centers The test will be offered to customers as a rapid PCR test with sample processing on site Commercial operations expected t
VANCOUVER, British Columbia, June 15, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience accelerator focused on next-generation
XPhyto Therapeutics says it is rapidly advancing its mescaline program for psychedelic therapies
08:01am, Tuesday, 08'th Jun 2021
XPhyto Therapeutics Corp (CSE:XPHY) (OTCMKTS:XPHYF) (FRA:4XT) has announced that its Good Manufacturing Practices (GMP) mescaline synthesis program is “on schedule” with the completion of initial
XPhyto Provides Progress Report on Mescaline Program for Psychedelic Therapies
03:05am, Tuesday, 08'th Jun 2021
Research and development lab set up, preliminary mescaline synthesis complete Modified synthesis process developed, mescaline batches manufactured Development of analytical methods and validation, GMP
XPhyto Therapeutics' partner Max Pharma to launch sale of Covid-ID Lab test in Germany from May 25
08:06am, Thursday, 20'th May 2021
XPhyto Therapeutics Corp (CSE:XPHY) (OTCQB:XPHYF) (FRA:4XT) told investors that its rapid point-of-care coronavirus (COVID-19) PCR test will be available to buy in Germany from May 25, 2021. The gro
XPhyto advances its Rotigotine drug delivery system for Parkinson's skin patches to a pivotal human trial
08:36am, Thursday, 13'th May 2021
XPhyto Therapeutics Corp (CSE:XPHY) (OTCMKTS:XPHYF) (FRA:4XT) offered investors an update on its transdermal delivery system for the neurologic drug Rotigotine, saying that based on “encouraging stu
XPhyto is advancing its Rotigotine drug delivery system for Parkinson's skin patches to a pivotal human trial
08:11am, Thursday, 13'th May 2021
XPhyto Therapeutics Corp (CSE:XPHY) (OTCMKTS:XPHYF) (FRA:4XT) offered investors an update on its transdermal delivery system for the neurologic drug Rotigotine, saying that based on “encouraging stu
XPhyto Establishes Proof of Concept Station for Point-of-Care 25-minute COVID-19 PCR Test in Germany
03:05am, Friday, 07'th May 2021
Pilot project includes point-of-care sample collection, PCR processing and final testing of workflow logistics Project is in cooperation with a German pharmacy currently running a COVID-19 test center
XPhyto Therapeutics pursues market access in Israel for its rapid 25-minute Covid-ID Lab test
07:48am, Wednesday, 28'th Apr 2021
XPhyto Therapeutics Corp (CSE:XPHY) (OTCQB:XPHYF) (FRA:4XT) revealed that it has delivered 2,000 of its 25-minute coronavirus (COVID-19) RT-PCR test kits called Covid-ID Lab to an established medical
XPhyto Pursues Market Access in Israel for its COVID-19 PCR Rapid Test
03:05am, Wednesday, 28'th Apr 2021
XPhyto delivered 2,000 of its 25-minute PCR tests to Israeli distributor for clinical evaluation and regulatory approval Potential customers include government institutions, private healthcare provide
XPhyto Therapeutics takes 'critical' step towards commercial sales of Covid-ID Lab test in Germany
07:36am, Wednesday, 21'st Apr 2021
XPhyto Therapeutics Corp (CSE:XPHY) (OTCQB:XPHYF) FRA:4XT) said it has taken a step towards commercializing its 25-minute coronavirus (COVID-19) RT-PCR test called Covid-ID Lab in Germany, striking a
XPhyto Signs German Distribution, Storage and Logistics Agreement for 25-Minute COVID-19 PCR Test
03:05am, Wednesday, 21'st Apr 2021
VANCOUVER, BC / ACCESSWIRE / April 21, 2021 / XPhyto Therapeutics Corp. (CSE:XPHY / OTCQB:XPHYF / FSE:4XT) ("XPhyto" or the "Company") is pleased to announce that it has entered into an agreement (the
Wall Street in the red again this week
12:30pm, Tuesday, 20'th Apr 2021
12:25pm: Airlines hit turbulence The Dow was down 238 points, 0.7%, to 33,839 at midday. The Nasdaq Composite declined 126 points, 0.9%, to 13,789, and the S&P 500 slid 28 points, 0.7%, to 4,135.
